Personal Statement
I am a child and adolescent psychiatrist with experience in delivering guideline-based care for child and adolescent psychiatric disorders. I am the Medical Director of the Outpatient Psychiatry Clinics at Seattle Children’s, and have experience with training of staff to deliver guideline-based care. I also have health services training, including having obtained a Master of Public Health (MPH) in Health Services and participation in a Primary Care-Psychiatry Research Fellowship funded by the National Institutes of Health.
My clinical work includes treatment of outpatients and inpatients with a variety of mental health needs, and I provide telepsychiatry in our outpatient clinics. I have experience with collaboration with primary care providers to deliver care to pediatric patients, including serving as a consulting psychiatrist on the Partnership Access Line, which provides psychiatric consultation regarding mental health assessment and treatment to pediatricians and other primary care physicians throughout the state of Washington. I have expertise in the treatment of common mental health problems in a pediatric population.
My research has focused on mental health care for common psychiatric illnesses including depression and ADHD, and has included utilization of collaborative models of care and testing of interventions for youth with psychiatric diagnoses. I have been a co-investigator, with R01 PI Kathleen Myers, MD, for a study of guideline-based care provided by telepsychiatry for youth in rural communities with a diagnosis of Attention Deficit Hyperactivity Disorder.
Personal Statement
My research aims to improve the public health impact of evidence-based behavioral health interventions for addressing comorbidities common among ethnoculturally diverse and underserved victims of trauma, including PTSD, depression, suicidal ideation, and risky substance use. I study the integration of behavioral interventions into general medical settings, with an emphasis on provider-centered training methods to support the delivery of patient-centered interventions. My current interest is in harnessing technologic innovations in machine learning and artificial intelligence, along with user-centered design, to enhance suicide prevention training scalability and sustainability. https://darnell.psychiatry.uw.edu/
Personal Statement
I am Professor and Associate Director for Evidence-Based Psychosocial Interventions at the AIMS Center, and Director of the National Network of PST Clinicians, Trainers & Researchers. In these roles, I develop and lead implementation and training programs in a variety of behavioral health interventions.
Personal Statement
I am a geriatric psychiatrist and health services researcher. My research focuses on ways of improving mental health and well-being among older adults, especially those with dementia and their caregivers.
Personal Statement
I am a psychiatric epidemiologist with interests in the etiology and prevention of substance use, internalizing mental health problems, and their co-occurrence. My research explores these phenomena across multiple levels of influence–from within-individual factors that can vary over time to broader neighborhood- and other area-level contextual factors. I am also interested in the application of innovative epidemiologic and statistical methods.
Personal Statement
Dr. Sylvers serves as the Director of Psychology Training at the Veterans Affairs Puget Sound Health Care System, American Lake Division. His primary research interests include personality and its relation to treatment outcomes, treatment outcomes related to trauma and anxiety related disorders, and the etiology and treatment of aggressive behavior. Dr. Sylvers also serves as a consultant for the Department of Veterans Affairs Acceptance and Commitment Therapy for Depression training initiative.
Personal Statement
My clinical service and research focuses on the interaction of mental and physical illness, especially in patients with chronic pain. Much of my research in recent decades has focused on the risks of treating chronic pain with opioids. I have developed educational programs and outcome tracking tools to assist with opioid treatment of chronic pain. I have published a book about patient empowerment in chronic disease care, The Patient as Agent of Health and Health Care (Oxford, 2017). I have another book written with Jane Ballantyne forthcoming, The Right to Pain Relief and other deep roots of the opioid epidemic (Oxford, 2022).
Personal Statement
My primary interests are in diagnostic evaluation, psychiatric methods, psychosomatic medicine, fatigue syndromes, pain disorders, abnormal illness behaviors, and human temperament and personality. I have conducted research jointly with colleagues at the University of Washington and the University of Washington Twin Registry on chronic widespread pain, depression and related phenomena.
Personal Statement
Over the last 25 years, my work has focused on relationships between stress and health in several risk groups (spouse caregivers of persons with Alzheimer’s disease, medical students, psychiatric/medical outpatients/inpatients, air traffic controllers, and camp counselors). We have developed and/or revised measures of medical student stress, caregiver burden, patient anger/dyscontrol, process coping, appraisal, neuropsychological function and physician awareness of patient problems. These measures have been used by university researchers, insurance companies, pharmaceutical companies in clinical trials, prisons, nursing homes/long term care, rehabilitation facilities, and public health organizations. These psychosocial and behavioral measures have been shown to predict and be predicted by physiological and cognitive measures. We have also focused on moderators of such relationships, such as gender, personality, and co-morbidities. We have used primarily multicohort long-term studies that allow for interactions between exposures to stressors, hard-wired vulnerabilities, and more temporal resources. We attempted to identify mechanisms that can be potentially altered to have long-term public health significance in persons under chronic stress. I have also attempted to isolate groups that are at high risk for negative outcomes. In a perfect world, interventions should be used to help all persons who have deleterious responses to stress, but society cannot afford this. For this reason, the identification of high risk groups is imperative for maximizing the effect of interventions.
My research program’s long range goal is to better understand the mechanisms by which chronic stress translates into physical, mental, or cognitive health problems. We are examining caregivers of spouses with AD and demographically-similar spouse non-caregivers across time and assessing the degree to which elevated depression, stress hormones, inflammation, and insulin resistance in caregivers predict cognitive decline in caregivers relative to non-caregivers. We are also attempting to replicate our earlier work that showed that chronic stress and chronic disease moderate each other’s physiological risks. For example, physiological dysregulation that is specific to a disease (e.g., metabolic syndrome with CHD, blood pressure reactivity with hypertension, and immune function with cancer history, HbA1c with diabetes) is exacerbated in caregivers with a chronic disease relative to non-caregivers with a chronic disease, but no such differences occur in caregivers versus non-caregivers without a chronic disease. Finally, we are examining a large cohort of older adults sampled from various U.S. communities in order to assess the influence of life stressors on long term cognitive function and potential mediators of such changes.
